Burstable Health Team
Health In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
3004 articles
Articles
Tonix Pharmaceuticals Reports Strong Q2 Revenue Growth Driven by TONMYA Sales
Tonix Pharmaceuticals announced Q2 2026 net product revenue of $13.5 million, largely from TONMYA fibromyalgia treatment, with significant prescription growth and pipeline advancements.
August 10, 2026Read the full article
Tonix Pharmaceuticals Reports Q2 Revenue Surge as TONMYA Sales Reach $11 Million
Tonix Pharmaceuticals' Q2 2026 revenue jumped to $13.5 million, driven by TONMYA's strong performance, with expanding coverage and pipeline progress signaling growth in fibromyalgia and CNS treatments.
August 10, 2026Read the full article
Breastfeeding Month: Expert Urges Support and Science Over Shame in Infant Feeding Decisions
Dr. Savita Srivastava highlights the benefits of breast milk for infant gut health while emphasizing that parents need practical support and evidence-based guidance, not guilt, in their feeding choices.
August 10, 2026Read the full article
Las Vegas CME Conference Offers Up to 26 Credits for Healthcare Professionals
Skin, Bones, Hearts & Private Parts will host a CME conference in Las Vegas, NV, from November 10-13, offering up to 26 CME credits and 4.5 APRN Pharmacology credits, with expert-led sessions on cardiology, orthopedics, endocrinology, and more.
August 10, 2026Read the full article
OffScript Launches Fully Disclosed Nootropic Mints for Focus and Stress
OffScript introduces two sublingual nootropic mint lines with transparent labeling and third-party testing, targeting daily focus and stress resilience in the portable supplement market.
August 8, 2026Read the full article
Quantum BioPharma Advances Dual Strategy Targeting Neurological Health with Lucid-MS and unbuzzd
Quantum BioPharma is developing a two-pronged approach to neurological health, including a potential MS therapy and a supplement for alcohol effects, with recent regulatory and clinical progress.
August 7, 2026Read the full article
Spanish Patient's Pork Tapeworm Infection Mimics Brain Cancer, Highlighting Diagnostic Challenges
Doctors in Spain treated a patient for brain cancer-like symptoms, but the cause was a pork tapeworm infection, underscoring risks of undercooked pork and the need for better diagnostics.
August 7, 2026Read the full article
Lantern Pharma to Webcast Second-Quarter 2026 Results and AI Platform Updates
Lantern Pharma will discuss its Q2 2026 financial results and provide updates on its AI-driven oncology pipeline, including the commercial launch of Zeta.ai, which opens a new revenue stream.
August 7, 2026Read the full article
TNT Highlights Key Quality Standards for Creatine as Consumer Demand Grows
German sports nutrition company True Nutrition Technology educates consumers on what distinguishes high-quality creatine, emphasizing manufacturing standards, purity, and sourcing.
August 7, 2026Read the full article
ORGANA International Highlights Fulvic Minerals as Consumer Interest in Plant-Derived Nutrition Grows
As consumers seek transparency in wellness ingredients, ORGANA International emphasizes the role of fulvic minerals and plant-derived nutrition in modern health routines.
August 7, 2026Read the full article
Wolfson Group Highlights Growing Consumer Interest in Cognitive Wellness
Wolfson Group's expansion of NooCube in the U.S. reflects rising consumer demand for cognitive wellness products, emphasizing transparency and quality.
August 7, 2026Read the full article
RHON-KLINIKUM AG Reports Stable First Half of 2026, Emphasizes Regional Networks Amid Healthcare Reforms
RHON-KLINIKUM AG's stable H1 2026 results highlight the importance of regional healthcare networks and the financial pressures from new German hospital reforms.
August 6, 2026Read the full article
VERAXA Biotech Advances VXA-222 Cancer Program and Expands Patent Portfolio for Next-Generation Antibody Technologies
VERAXA Biotech has moved its VXA-222 bispecific antibody-drug conjugate into the next development stage after completing the discovery phase with OmniAb, while expanding its intellectual property portfolio with new patents, signaling progress in its oncology pipeline.
August 6, 2026Read the full article
July Wellness Index Report Highlights Shift from Overriding Biology to Restoring Body's Natural Functions
The July Wellness Index Report reveals a trend in longevity medicine toward working with the body's own hormones, cells, and microbiome, featuring International Pause Institute, PUR-FORM, and FitBiomics.
August 6, 2026Read the full article
Regentis GelrinC Gains European Approval for Next-Gen Manufacturing, Boosting Production Yield by 400%
Regentis Biomaterials received European regulatory approval for a next-generation GelrinC manufacturing process that increases production yield by 400%, positioning the cell-free hydrogel as a scalable, cost-effective standard of care for knee cartilage repair.
August 5, 2026Read the full article
Earth Science Tech Advances Telehealth Position Through Technology and Vertical Integration
Earth Science Tech is leveraging proprietary technology and vertical integration to strengthen its position in the growing telehealth and peptide therapy markets.
August 5, 2026Read the full article
LataMed AI to Discuss AI in Healthcare and Systems Engineering at Universidad Santa Maria
LataMed AI will present at a university conference in Venezuela to discuss the responsible integration of AI in healthcare and systems engineering, highlighting its platforms CardioAI, PulmoAI, and NeuroAI.
August 5, 2026Read the full article
NeuroThera Labs Initiates Phase IIb Trial for Tourette Syndrome Treatment at Yale Child Study Center
NeuroThera Labs has launched a Phase IIb clinical trial for SCI-110, a novel cannabinoid-based treatment for Tourette Syndrome, at Yale Child Study Center, marking a significant step toward addressing an unmet medical need.
August 5, 2026Read the full article
Even Light Activity May Lower Stroke, Death Risk in People With Atrial Fibrillation
New research shows that physical activity, even at low levels, is associated with a reduced risk of stroke and death in adults with and without atrial fibrillation, highlighting the importance of exercise as a preventive strategy.
August 5, 2026Read the full article
The Harvest Table Urges Consumers to Prioritize Ingredient Labels Over Marketing Claims
South African wellness brand The Harvest Table emphasizes the importance of reading ingredient labels to make informed, clean-label nutrition choices, highlighting its products available on Amazon.
August 5, 2026Read the full article
VetosEurope Wins Four Awards for Sustainable Cattle Farming Innovations
VetosEurope has been honored with four awards from World Business Outlook for its methane-reducing feed additive Anavrin, which combines productivity gains with climate impact, positioning the company as a leader in sustainable agriculture.
August 5, 2026Read the full article